litlas
ログインアカウント作成

Robert R. Henry

1973–2023 年に発表

138
論文数
34,243
被引用数
98
h 指数
129
i10 指数

被引用数

Robert R. Henry の年別被引用数1976 年: 被引用 9 件1977 年: 被引用 13 件1978 年: 被引用 1 件1979 年: 被引用 1 件1980 年: 被引用 7 件1981 年: 被引用 1 件1982 年: 被引用 5 件1983 年: 被引用 3 件1984 年: 被引用 3 件1985 年: 被引用 8 件1986 年: 被引用 8 件1987 年: 被引用 16 件1988 年: 被引用 23 件1989 年: 被引用 21 件1990 年: 被引用 20 件1991 年: 被引用 37 件1992 年: 被引用 42 件1993 年: 被引用 36 件1994 年: 被引用 50 件1995 年: 被引用 66 件1996 年: 被引用 58 件1997 年: 被引用 96 件1998 年: 被引用 104 件1999 年: 被引用 96 件2000 年: 被引用 125 件2001 年: 被引用 169 件2002 年: 被引用 176 件2003 年: 被引用 206 件2004 年: 被引用 247 件2005 年: 被引用 229 件2006 年: 被引用 216 件2007 年: 被引用 245 件2008 年: 被引用 260 件2009 年: 被引用 245 件2010 年: 被引用 221 件2011 年: 被引用 224 件2012 年: 被引用 272 件2013 年: 被引用 314 件2014 年: 被引用 353 件2015 年: 被引用 335 件2016 年: 被引用 399 件2017 年: 被引用 356 件2018 年: 被引用 412 件2019 年: 被引用 1,060 件2020 年: 被引用 1,083 件2021 年: 被引用 961 件2022 年: 被引用 684 件2023 年: 被引用 509 件2024 年: 被引用 763 件2025 年: 被引用 412 件2026 年: 被引用 12 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,137 件、この内訳の 27.8%中国: 引用元論文 1,163 件、この内訳の 7.8%イギリス: 引用元論文 1,017 件、この内訳の 6.8%イタリア: 引用元論文 679 件、この内訳の 4.6%ドイツ: 引用元論文 669 件、この内訳の 4.5%カナダ: 引用元論文 600 件、この内訳の 4%オーストラリア: 引用元論文 442 件、この内訳の 3%デンマーク: 引用元論文 385 件、この内訳の 2.6%フランス: 引用元論文 384 件、この内訳の 2.6%日本: 引用元論文 353 件、この内訳の 2.4%スウェーデン: 引用元論文 340 件、この内訳の 2.3%インド: 引用元論文 336 件、この内訳の 2.3%
0%27.8%その他 29.3%

機関

分野

  • Medicine64.3%
  • Biochemistry, Genetics and Molecular Biology19.5%
  • Computer Science6.9%
  • Neuroscience3.1%
  • Nursing1.3%
  • Agricultural and Biological Sciences0.7%
  • その他4.2%

トピック

  • Diabetes Treatment and Management8%
  • Pancreatic function and diabetes4.8%
  • Metabolism, Diabetes, and Cancer4.8%
  • Adipose Tissue and Metabolism4.1%
  • Adipokines, Inflammation, and Metabolic Diseases3.9%
  • Diabetes Management and Research3.6%
  • その他70.8%

共著者

全論文

検索で開く
  1. Type 2 diabetes mellitus

    著者: Ralph A. DeFronzo, Ele Ferrannini, Leif Groop, Robert R. Henry, William H. Herman, Jens J. Holst, Frank B. Hu, C. Ronald Kahn, Itamar Raz, Gerald I. Shulman, Donald C. Simonson, Marcia A. Testa, Ram Weiss - Nature Reviews Disease Primers 2015 被引用: 2,547

  2. Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

    著者: Sunder Mudaliar, Robert R. Henry, Arun J. Sanyal, Linda Morrow, Hanns–Ulrich Marschall, Mark Kipnes, Luciano Adorini, Cathi Sciacca, Paul Clopton, Erin Castelloe, Paul Dillon, Mark Pruzanski, Д. А. Шапиро - Gastroenterology 2013 被引用: 915

  3. SGLT2 inhibition — a novel strategy for diabetes treatment

    著者: Edward C. Chao, Robert R. Henry - Nature Reviews Drug Discovery 2010 被引用: 810

  4. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors

    著者: William H. Polonsky, Robert R. Henry - Patient Preference and Adherence 2016 被引用: 769

  5. Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial

    著者: Alan J. Garber, Robert R. Henry, Robert E. Ratner, Pedro Alberto García-Hernández, Hiromi Rodriguez-Pattzi, Israel Olvera-Alvarez, Paula M. Hale, Milan Zdravkovic, Bruce W. Bode - The Lancet 2008 被引用: 1,053

  6. Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes

    著者: Satish K. Garg, Robert R. Henry, Phillip Banks, John B. Buse, Melanie J. Davies, Gregory Fulcher, Paolo Pozzilli, Diane Gesty‐Palmer, Pablo Lapuerta, Rafael Simó, Thomas Danne, Darren K. McGuire, Jake A. Kushner, Anne L. Peters, Paul Strumph - New England Journal of Medicine 2017 被引用: 416

  7. Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes

    著者: Kenneth Cusi, Fernando Bril, Diana Barb, David Polidori, Sue Sha, Atalanta Ghosh, Kristin Farrell, Nishanth E. Sunny, Srilaxmi Kalavalapalli, Jeremy Pettus, Theodore P. Ciaraldi, Sunder Mudaliar, Robert R. Henry - Diabetes Obesity and Metabolism 2018 被引用: 197

  8. International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors

    著者: Thomas Danne, Satish K. Garg, Anne L. Peters, John B. Buse, Chantal Mathieu, Jeremy Pettus, Charles M. Alexander, Tadej Battelino, Francisco Javier Ampudia‐Blasco, Bruce W. Bode, Bertrand Cariou, Kelly L. Close, Paresh Dandona, Sanjoy Dutta, Ele Ferrannini, Spiros Fourlanos, George Grunberger, Simon Heller, Robert R. Henry, Martin J. Kurian, Jake A. Kushner, Tal Oron, Christopher G. Parkin, Thomas R. Pieber, Helena W. Rodbard, Desmond Schatz, Jay S. Skyler, William V. Tamborlane, Koutaro Yokote, Moshe Phillip - Diabetes Care 2019 被引用: 356

  9. Impaired Fasting Glucose and Impaired Glucose Tolerance

    著者: David M. Nathan, Mayer B. Davidson, Ralph A. DeFronzo, Robert J. Heine, Robert R. Henry, Richard E. Pratley, Bernard Zinman - Diabetes Care 2007 被引用: 1,395

  10. Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis

    著者: Sunder Mudaliar, Sindura Alloju, Robert R. Henry - Diabetes Care 2016 被引用: 566

  11. Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance

    著者: Ralph A. DeFronzo, Devjit Tripathy, Dawn C. Schwenke, MaryAnn Banerji, George A. Bray, Thomas A. Buchanan, Stephen Clement, Robert R. Henry, Howard N. Hodis, Abbas E. Kitabchi, Wendy J. Mack, Sunder Mudaliar, Robert E. Ratner, Ken Williams, Frankie B. Stentz, Nicolas Musi, Peter D. Reaven - New England Journal of Medicine 2011 被引用: 743

  12. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of SGLT-2 Inhibitors and Diabetic Ketoacidosis

    著者: Yehuda Handelsman, Robert R. Henry, Zachary T. Bloomgarden, Sam Dagogo‐Jack, Ralph A. DeFronzo, Daniel Einhorn, Ele Ferrannini, Vivian Fonseca, Alan J. Garber, George Grunberger, Derek LeRoith, Guillermo E. Umpierrez, Matthew R. Weir - Endocrine Practice 2016 被引用: 357

  13. Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes

    著者: John B. Buse, Robert R. Henry, Jenny Han, Dennis Dong Hwan Kim, Mark Fineman, Alain Baron - Diabetes Care 2004 被引用: 1,345

  14. Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects

    著者: Timothy E. Graham, Qin Yang, Matthias Blüher, Ann Hammarstedt, Theodore P. Ciaraldi, Robert R. Henry, Christopher J. Wason, Andreas Oberbach, Per‐Anders Jansson, Ulf Smith, Barbara B. Kahn - New England Journal of Medicine 2006 被引用: 1,309

  15. Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier

    著者: Ajit S. Divakaruni, Sandra E. Wiley, George W. Rogers, Alexander Y. Andreyev, Susanna Petrosyan, Mattias Loviscach, Estelle A. Wall, Nagendra Yadava, Alejandro P. Heuck, David A. Ferrick, Robert R. Henry, William Graham McDonald, Jerry R. Colca, Melvin I. Simon, Theodore P. Ciaraldi, Anne N. Murphy - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 被引用: 310

  16. A PPARγ–FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis

    著者: Johan W. Jonker, Jae Myoung Suh, Annette R. Atkins, Maryam Ahmadian, Pingping Li, Jamie Whyte, Ming‐Xiao He, Henry Juguilon, Yunqiang Yin, Colin T. Phillips, Ruth T. Yu, Jerrold M. Olefsky, Robert R. Henry, Michael Downes, Ronald M. Evans - Nature 2012 被引用: 271

  17. Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers

    著者: Robert R. Henry, Theodore P. Ciaraldi, Debra Armstrong, P. Burke, Monica Ligueros‐Saylan, Sunder Mudaliar - The Journal of Clinical Endocrinology & Metabolism 2013 被引用: 250

  18. Initial Clinical Evaluation of VC-01TM Combination Product—A Stem Cell–Derived Islet Replacement for Type 1 Diabetes (T1D)

    著者: Robert R. Henry, Jeremy Pettus, Jon S. Wilensky, A. M. James Shapiro, Peter Senior, Bart O. Roep, Richard Wang, Evert Kroon, Michael M. Scott, Kevin A. D’Amour, Howard L. Foyt - Diabetes 2018 被引用: 109

  19. Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier

    著者: Nathaniel M. Vacanti, Ajit S. Divakaruni, Courtney R. Green, Seth J. Parker, Robert R. Henry, Theodore P. Ciaraldi, Anne N. Murphy, Christian M. Metallo - Molecular Cell 2014 被引用: 287

  20. Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release

    著者: W. Timothy Garvey, Donna H. Ryan, Robert R. Henry, Nancy J.V. Bohannon, Hermann Toplak, Michael Schwiers, Barbara Troupin, Wesley Day - Diabetes Care 2013 被引用: 213

  21. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity

    著者: Harold Bays, J. Michael González-Campoy, George A. Bray, Abbas E. Kitabchi, Donald A. Bergman, Alan B. Schorr, Helena W. Rodbard, Robert R. Henry - Expert Review of Cardiovascular Therapy 2008 被引用: 531

  22. Efficacy and safety of alirocumab in insulin‐treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM‐INSULIN randomized trial

    著者: Lawrence A. Leiter, Bertrand Cariou, Dirk Müller‐Wieland, Helen M. Colhoun, Stefano Del Prato, Francisco J. Tinahones, Kausik K. Ray, Maja Bujas‐Bobanovic, Catherine Domenger, Jonas Mandel, Rita Samuel, Robert R. Henry - Diabetes Obesity and Metabolism 2017 被引用: 140

  23. Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm – 2016 EXECUTIVE SUMMARY

    著者: Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo‐Jack, Ralph A. DeFronzo, Daniel Einhorn, Vivian Fonseca, Jeffrey R. Garber, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Robert R. Henry, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez - Endocrine Practice 2016 被引用: 875

  24. Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary Glucose Excretion

    著者: David Polidori, Sue Sha, Sunder Mudaliar, Theodore P. Ciaraldi, Atalanta Ghosh, Nicole Vaccaro, Kristin Farrell, Paul Rothenberg, Robert R. Henry - Diabetes Care 2013 被引用: 263